Clinical Trial Update: A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical trial is evaluating multiple combination therapies with FWD1802 in ER+/HER2- breast cancer and related stages, and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• FWD1802

Snippet

Sponsor: Forward Pharmaceuticals Co., Ltd. | Conditions: Metastatic Breast Cancer, Breast Cancer Stage I | Phase 1, Phase 2 | Status: RECRUITING